Interested in Participating?

A clinical trial is now available for those whose cancer has spread to the skin and hasn’t responded to other treatments.

T

he prostate is a gland of the male reproductive system that aids in the creation and transportation of seminal fluid. Though during most of a man’s life the prostate is about the size of a walnut and only weighs about 11 grams, as men get older it can begin to enlarge, weighing up to 70 grams.

An enlarged prostate gland is the main complaint of men over the age of 50, and it is estimated that about 1 in every 9 men 65 years and older will be diagnosed with prostate cancer at some point. As with any other kind of cancer, prostate cancer beings when cells begin to grow and divide uncontrollably, but it rarely causes any symptoms.

In addition to usually being asymptomatic, prostate cancer tends to grow very slowly. This means that the vast majority of patients are diagnosed at a very early stage and have pretty good chances of survival.

Because prostate cancer is the second most common type of cancer in men, doctors recommend that all males over the age of 50 (or earlier if they have a prostate cancer family history) undergo a routine prostate screening test. Typically, a routine prostate cancer checkup is performed by a urologist, which is a doctor that specializes in the male reproductive system.

These screenings it usually involves a manual examination to check the size of the prostate, and a blood test to look for elevated prostate-specific antigen (PSA). If the doctor considers that any or both of these tests are altered they may recommend a biopsy to check for cancer cells in the prostate or surrounding tissues.

Match to Prostate Cancer Clinical Trials

  • Access to cutting-edge treatments
  • Latest clinical trials
  • Find trials in your area

What Are Prostate Cancer Clinical Trials?

A clinical trial is a research study performed by doctors, scientists, or researchers to test a new drug or intervention and determine both its safety and effectiveness. All new treatments and procedures have to be thoroughly evaluated by experts before being released to the public, which is a process that can take several years.

Prostate clinical trials aim to study different aspects of the disease; from new, less invasive ways to diagnosing cancer to alternative treatments that may improve and extend the lives of patients. Clinical trials have played a crucial role in the current prognosis of prostate cancer patients, and there are new trials being conducted every year aiming to improve the quality of life and outcomes of cancer patients.

Why Should I Enroll in a Prostate Cancer Clinical Trial?

Deciding to participate in a clinical trial is a very personal decision, and there are many reasons why a person might choose to take part in one. Some of the most common reasons why people decide to enroll in a trial are:

Personalized Medical Care

Although most medications or procedures administered during a clinical trial are still experimental, some individuals opt to volunteer in a trial because it gives them access to the latest treatment options for their condition. Moreover, participants usually receive around-the-clock medical attention from experts who closely monitor their condition.

Clinical Trials Help Others

Healthy volunteers also participate in clinical trials, and many of them do so because they see it as their way of helping others. Clinical trials are extremely important for developing new and better medical techniques that may save lives in the future. However, clinical trials would not be possible without those who volunteer their time to test these new advances.

Actively Participate in Your Own Healthcare

Getting involved in your own healthcare will allow you to get a better understanding of your condition and your options. Those who are more involved and aware of their health typically have better outcomes than those who don’t. Participating in a clinical trial gives you the opportunity to learn more about your condition and become more self-aware regarding your own health.

Interested in Participating?

A clinical trial is now available for those whose cancer has spread to the skin and hasn’t responded to other treatments.

How Can I Find a Clinical Trial?

As of this year, there are close to 300,000 active clinical trials for thousands of different conditions, and many of them are actively recruiting. If you or a loved one is a prostate cancer patient looking to enroll in a clinical trial, ask your doctor if they know of any studies that may be a good fit for you.

ClinicalTrials.gov: Recruiting Studies | Prostate Cancer | Last update posted in the last 300 days Studies found on ClinicalTrials.gov by a search of: Recruiting Studies | Prostate Cancer | Last update posted in the last 300 days

  • INTERVAL - Intense Exercise Trial for Men With Metastatic Castrate-Resistant Prostate Cancer
    on August 11, 2020 at 4:00 pm

    Condition:   Prostate CancerIntervention:   Other: Intensive Exercise InterventionSponsors:   Guy's and St Thomas' NHS Foundation Trust;   Movember Foundation;   Queen's University, Belfast;   University of Glasgow;   University of Bristol;   University of SurreyRecruiting

  • Improvement of Communicational Skills Between Health Workers and Oncological Patients During Medical Consultative Conversations
    on August 10, 2020 at 4:00 pm

    Condition:   Prostate CancerIntervention:   Behavioral: Audio recording of the counseling conversationSponsors:   I.M. Sechenov First Moscow State Medical University;   Institute of Linguistics and Intercultural CommunicationRecruiting

  • Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
    on August 6, 2020 at 4:00 pm

    Conditions:   Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8;   Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8;   Clinical Stage 0 Gastric Cancer AJCC v8;   Clinical Stage I Esophageal Adenocarcinoma AJCC v8;   Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8;   Clinical Stage I Gastric Cancer AJCC v8;   Clinical Stage II Esophageal Adenocarcinoma AJCC v8;   Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8;   Clinical Stage II Gastric Cancer AJCC v8;   Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8;   Clinical Stage IIA Gastric Cancer AJCC v8;   Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8;   Clinical Stage IIB Gastric Cancer AJCC v8;   Clinical Stage III Esophageal Adenocarcinoma AJCC v8;   Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8;   Clinical Stage III Gastric Cancer AJCC v8;   Clinical Stage IV Esophageal Adenocarcinoma AJCC v8;   Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8;   Clinical Stage IV Gastric Cancer AJCC v8;   Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8;   Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8;   Clinical Stage IVA Gastric Cancer AJCC v8;   Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8;   Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8;   Clinical Stage IVB Gastric Cancer AJCC v8;   Hepatobiliary Neoplasm;   Malignant Digestive System Neoplasm;   Malignant Female Reproductive System Neoplasm;   Malignant Genitourinary System Neoplasm;   Malignant Neoplasm;   Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage 0 Gastric Cancer AJCC v8;   Pathologic Stage I Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage I Gastric Cancer AJCC v8;   Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage IA Gastric Cancer AJCC v8;   Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage IB Gastric Cancer AJCC v8;   Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage II Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage II Gastric Cancer AJCC v8;   Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage IIA Gastric Cancer AJCC v8;   Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage IIB Gastric Cancer AJCC v8;   Pathologic Stage III Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage III Gastric Cancer AJCC v8;   Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage IIIA Gastric Cancer AJCC v8;   Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage IIIB Gastric Cancer AJCC v8;   Pathologic Stage IIIC Gastric Cancer AJCC v8;   Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IV Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage IV Gastric Cancer AJCC v8;   Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8;   Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8;   Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8;   Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8;   Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8;   Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8;   Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8;   Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8;   Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8;   Stage 0 Colorectal Cancer AJCC v8;   Stage 0a Bladder Cancer AJCC v8;   Stage 0is Bladder Cancer AJCC v8;   Stage I Bladder Cancer AJCC v8;   Stage I Cervical Cancer AJCC v8;   Stage I Colorectal Cancer AJCC v8;   Stage I Ovarian Cancer AJCC v8;   Stage I Prostate Cancer AJCC v8;   Stage I Renal Cell Cancer AJCC v8;   Stage I Uterine Corpus Cancer AJCC v8;   Stage IA Cervical Cancer AJCC v8;   Stage IA Ovarian Cancer AJCC v8;   Stage IA Uterine Corpus Cancer AJCC v8;   Stage IA1 Cervical Cancer AJCC v8;   Stage IA2 Cervical Cancer AJCC v8;   Stage IB Cervical Cancer AJCC v8;   Stage IB Ovarian Cancer AJCC v8;   Stage IB Uterine Corpus Cancer AJCC v8;   Stage IB1 Cervical Cancer AJCC v8;   Stage IB2 Cervical Cancer AJCC v8;   Stage IC Ovarian Cancer AJCC v8;   Stage II Bladder Cancer AJCC v8;   Stage II Cervical Cancer AJCC v8;   Stage II Colorectal Cancer AJCC v8;   Stage II Ovarian Cancer AJCC v8;   Stage II Prostate Cancer AJCC v8;   Stage II Renal Cell Cancer AJCC v8;   Stage II Uterine Corpus Cancer AJCC v8;   Stage IIA Cervical Cancer AJCC v8;   Stage IIA Colorectal Cancer AJCC v8;   Stage IIA Ovarian Cancer AJCC v8;   Stage IIA Prostate Cancer AJCC v8;   Stage IIA1 Cervical Cancer AJCC v8;   Stage IIA2 Cervical Cancer AJCC v8;   Stage IIB Cervical Cancer AJCC v8;   Stage IIB Colorectal Cancer AJCC v8;   Stage IIB Ovarian Cancer AJCC v8;   Stage IIB Prostate Cancer AJCC v8;   Stage IIC Colorectal Cancer AJCC v8;   Stage IIC Prostate Cancer AJCC v8;   Stage III Bladder Cancer AJCC v8;   Stage III Cervical Cancer AJCC v8;   Stage III Colorectal Cancer AJCC v8;   Stage III Ovarian Cancer AJCC v8;   Stage III Prostate Cancer AJCC v8;   Stage III Renal Cell Cancer AJCC v8;   Stage III Uterine Corpus Cancer AJCC v8;   Stage IIIA Bladder Cancer AJCC v8;   Stage IIIA Cervical Cancer AJCC v8;   Stage IIIA Colorectal Cancer AJCC v8;   Stage IIIA Ovarian Cancer AJCC v8;   Stage IIIA Prostate Cancer AJCC v8;   Stage IIIA Uterine Corpus Cancer AJCC v8;   Stage IIIA1 Ovarian Cancer AJCC v8;   Stage IIIA2 Ovarian Cancer AJCC v8;   Stage IIIB Bladder Cancer AJCC v8;   Stage IIIB Cervical Cancer AJCC v8;   Stage IIIB Colorectal Cancer AJCC v8;   Stage IIIB Ovarian Cancer AJCC v8;   Stage IIIB Prostate Cancer AJCC v8;   Stage IIIB Uterine Corpus Cancer AJCC v8;   Stage IIIC Colorectal Cancer AJCC v8;   Stage IIIC Ovarian Cancer AJCC v8;   Stage IIIC Prostate Cancer AJCC v8;   Stage IIIC Uterine Corpus Cancer AJCC v8;   Stage IIIC1 Uterine Corpus Cancer AJCC v8;   Stage IIIC2 Uterine Corpus Cancer AJCC v8;   Stage IV Bladder Cancer AJCC v8;   Stage IV Cervical Cancer AJCC v8;   Stage IV Colorectal Cancer AJCC v8;   Stage IV Ovarian Cancer AJCC v8;   Stage IV Prostate Cancer AJCC v8;   Stage IV Renal Cell Cancer AJCC v8;   Stage IV Uterine Corpus Cancer AJCC v8;   Stage IVA Bladder Cancer AJCC v8;   Stage IVA Cervical Cancer AJCC v8;   Stage IVA Colorectal Cancer AJCC v8;   Stage IVA Ovarian Cancer AJCC v8;   Stage IVA Prostate Cancer AJCC v8;   Stage IVA Uterine Corpus Cancer AJCC v8;   Stage IVB Bladder Cancer AJCC v8;   Stage IVB Cervical Cancer AJCC v8;   Stage IVB Colorectal Cancer AJCC v8;   Stage IVB Ovarian Cancer AJCC v8;   Stage IVB Prostate Cancer AJCC v8;   Stage IVB Uterine Corpus Cancer AJCC v8;   Stage IVC Colorectal Cancer AJCC v8Interventions:   Procedure: Patient Monitoring;   Other: Questionnaire AdministrationSponsors:   City of Hope Medical Center;   National Cancer Institute (NCI)Recruiting

  • Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency
    on July 30, 2020 at 4:00 pm

    Condition:   Hormone-Sensitive Prostate CancerInterventions:   Drug: Capivasertib;   Other: Placebo;   Drug: Abiraterone AcetateSponsor:   AstraZenecaRecruiting

  • Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
    on July 28, 2020 at 4:00 pm

    Conditions:   Castration-Resistant Prostate Carcinoma;   Metastatic Malignant Neoplasm in the Bone;   Metastatic Prostate Carcinoma;   Stage IV Prostate Cancer AJCC v8;   Stage IVA Prostate Cancer AJCC v8;   Stage IVB Prostate Cancer AJCC v8Interventions:   Procedure: Biospecimen Collection;   Other: Questionnaire Administration;   Drug: Radium Ra 223 DichlorideSponsors:   University of Washington;   National Cancer Institute (NCI);   BayerRecruiting

  • 18F-PSMA-1007 PET Imaging to Detect Primary Prostate Cancer
    on July 27, 2020 at 4:00 pm

    Condition:   Prostate CancerIntervention:   Diagnostic Test: 18F-PSMA-1007 PET/CTSponsors:   Radboud University;   ABX advanced biochemical compounds GmbHRecruiting

  • TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
    on July 24, 2020 at 4:00 pm

    Condition:   Solid Tumor, AdultIntervention:   Drug: TTX-080Sponsor:   Tizona Therapeutics, IncRecruiting

  • Multicenter Study of Hypofractionated Postoperative Radiotherapy in Patients Diagnosed With Prostate Carcinoma
    on July 23, 2020 at 4:00 pm

    Condition:   Prostate CancerIntervention:   Radiation: hypofractionated postoperative radiation therapySponsor:   Grupo de Investigación Clínica en Oncología RadioterapiaRecruiting

  • Sarcopenia in Older Patient With Prostate Cancer, Prevalence and Incidence After Androgen Deprivation Therapy
    on July 23, 2020 at 4:00 pm

    Condition:   Prostate CancerIntervention:   Other: Prevalence of sarcopenia in older patient with prostate cancerSponsor:   Assistance Publique Hopitaux De MarseilleRecruiting

  • Prostate Screening for Men With Inherited Risk of Developing Aggressive Prostate Cancer, PATROL Study
    on July 15, 2020 at 4:00 pm

    Condition:   Prostate CarcinomaInterventions:   Procedure: Biospecimen Collection;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Other: Questionnaire AdministrationSponsors:   University of Washington;   National Cancer Institute (NCI)Recruiting

  • Impact of Acetazolamide in Reducing Referred Postoperative Pain
    on July 14, 2020 at 4:00 pm

    Conditions:   Prostate Cancer;   MenInterventions:   Drug: Acetazolamide;   Other: PlaceboSponsor:   Medical College of WisconsinRecruiting

  • EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer
    on July 10, 2020 at 4:00 pm

    Conditions:   Prostate Cancer;   Prostate AdenocarcinomaInterventions:   Radiation: External Beam Radiation;   Radiation: HDR Brachytherapy;   Drug: Androgen Deprivation TherapySponsor:   University of VirginiaRecruiting

Match to Prostate Cancer Clinical Trials

  • Access to cutting-edge treatments
  • Latest clinical trials
  • Find trials in your area
Sources